Coronado Biosciences to Report Third Quarter 2012 Financial Results
Published: Nov 07, 2012
BURLINGTON, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that it will report its financial results for the third quarter 2012 on Wednesday, November 14, 2012 at 8:30 AM EST. To participate in the conference call, please dial (877) 312-5413 (toll free from the US and Canada), or (253) 237-1511 (for international callers). Investors may also access a live audio webcast of the call at http://www.coronadobiosciences.com on the Events & Webcasts page.